iifl-logo-icon 1

Vikas Lifecare Ltd Board Meeting

5.34
(-2.02%)
Jul 8, 2024|03:32:11 PM

Vikas Lifecare CORPORATE ACTIONS

09/07/2023calendar-icon
08/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting19 Jun 202419 Jun 2024
CONVERSION OF 3,45,00,000 WARRANTS INTO EQUAL NUMBER OF EQUITY SHARES OF THE COMPANY
Board Meeting11 Jun 202411 Jun 2024
1. CONVERSION OF 1,28,00,000 WARRANTS INTO EQUAL NUMBER OF EQUITY SHARES OF THE COMPANY
Board Meeting1 Jun 20241 Jun 2024
Outcome of Board Meeting held on June 01, 2024
Board Meeting29 May 202413 May 2024
Vikas Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve and take on record the Audited Financial Results of the Company for quarter and financial year ended 31st March 2024; ii. to consider and approve any other item(s) with the permission of the Chair.
Board Meeting17 May 202417 May 2024
Outcome of the Board Meeting held today i.e. May 17, 2024.
Board Meeting18 Apr 202418 Apr 2024
Conversion of 56100000 Warrants into equal number of Equity Shares of the Company
Board Meeting5 Apr 20245 Apr 2024
Outcome of the Board Meeting held on April 5, 2024.
Board Meeting20 Mar 202420 Mar 2024
Outcome of Board Meeting held on March 20, 2024
Board Meeting2 Mar 20242 Mar 2024
Outcome of the Board Meeting held on March 2, 2024.
Board Meeting13 Feb 20247 Feb 2024
Vikas Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve take on record the (Standalone and Consolidated) Unaudited Financial Results of the Company along with Limited Review Report for the Quarter ended on December 31 2023; ii. To consider any other item(s) with the permission of the Chair Outcome of Board Meeting held on February 13, 2024 (As Per BSE Announcement dated on 13.02.2024)
Board Meeting8 Feb 20248 Feb 2024
Outcome of Board Meeting - Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (SEBI (LODR) Regulations, 2015)
Board Meeting31 Jan 202431 Jan 2024
Resignation of CEO of the Company Appointment of CEO of the Company Appointment of Chief Operating Officer of the Company Appointment of Independent Director of the Company
Board Meeting17 Oct 202311 Oct 2023
Vikas Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2023 inter alia to consider and approve and take on record the (Standalone and Consolidated) Unaudited Financial Results of the Company along with Limited Review Report for the Quarter and Half year ended on September 30 2023.; ii. To consider any other item(s) with the permission of the Chair. Outcome of Board Meeting held on October 17, 2023 Submission of Un-Audited Financial Results for the Quarter and half year ended September 30, 2023 (As per BSE Announcement Dated on 17/10/2023) Newspaper Advertisement of Un- Audited Financial Results of the Company for the Quarter and Half year ended September 30, 2023 (As Per BSE Announcement Dated on 19/10/2023)
Board Meeting6 Sep 20232 Sep 2023
Vikas Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2023 inter alia to consider and approve the increase in size of the preferential issue declared by the Board of Directors of the Company in their meeting held on August 31 2023 by inclusion of certain other strategic investors and take other decisions which may be incidental thereto and connected therewith. Outcome of Board Meeting held on Wednesday, September 06, 2023 (As per BSE Announcement Dated on 06/09/2023)
Board Meeting31 Aug 202326 Aug 2023
Vikas Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2023 inter alia to consider and approve Intimation of Board Meeting to be held on Thursday August 31 2023 1. Preferential Allotment to Promoter: to allot up to 10,00,00,000 (Ten Crores only) Compulsorily Convertible Warrants (Warrants), at premium, for cash to Mr. Vikas Garg, Promoter of the Company on preferential basis at an issue price of Rs. 4/- (Rupees Four Only) per Warrant, 2. Rescheduling of Annual General Meeting: re-scheduled/revise date/draft of the Annual General Meeting are as follows: (a) book closure for the purpose of 28th Annual General Meeting of the Company from September 24, 2023 to September 30, 2023 (both days inclusive). (b) 28th Annual General Meeting of the company, now it is to be held on Saturday, 30th September 2023 at 11:30 A.M. (As per BSE Announcement Dated on 31/08/2023)
Board Meeting12 Aug 20234 Aug 2023
Vikas Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve i. to consider approve and take on record the Un-Audited Financial Results of the Company along with the Limited Review Report for the quarter ended June 30 2023; ii. any other item(s) with the permission of the Chair. Outcome of Board Meeting held on August 12, 2023 (As per BSE Announcement Dated on 12/08/2023)

Vikas Lifecare: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.